IMATINIB DICHLOROACETATE AND ANTI-CANCER AGENT COMPRISING THE SAME
摘要
The present invention relates to imatinib dichloroacetate and an anti-cancer agent comprising the same. The imatinib dichloroacetate of the present invention can inhibit tyrosine kinase as well as induce cancer cells to kill themselves via apoptosis, thereby inhibit growth of cancer cells and lead to their destruction, and show significantly enhanced anti-cancer effects by synergy between imatinib and dichloroacetic acid.
申请公布号
WO2011081408(A2)
申请公布日期
2011.07.07
申请号
WO2010KR09423
申请日期
2010.12.28
申请人
CELLTRION CHEMICAL RESEARCH INSTITUTE;CELLTRION PHARM, INC.;KIM, KYOUNG SOO;PARK, YOUNG JUN;SONG, HYUN-NAM;KIM, JOON WOO
发明人
KIM, KYOUNG SOO;PARK, YOUNG JUN;SONG, HYUN-NAM;KIM, JOON WOO